Skip to main content

Table 1 Characteristics at baseline and follow up of the 71 patients with early RA

From: Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity

Variable Baseline Follow up P
Age 56.4 (12.7) - -
Female 47 (66%) - -
Duration of symptoms, months 10.3 (11.6) - -
Smoking status (current) 15 (21%) - -
Body mass index (kg/m2) 30.6 (7.2) - -
Rheumatoid factor-positive 55 (79%) - -
ACPA-positive 63 (89%) - -
CMV-IgG-positive 30 (42%) - -
EBV-IgG-positive 64 (90%) - -
DAS28-CRP (four-variable) 4.9 (1.0) 3.6 (1.3) <0.001
HAQ disability index 0.9 (0.5) 0.5 (0.6) <0.001
C-reactive protein (mg/L) 12.6 (18.0) 6.3 (7.9) 0.003
  1. Data are mean (SD) or number (%) as appropriate. RA, rheumatoid arthritis; ACPA, anti-citrullinated protein antibodies; DAS28, Disease Activity Score in 28 joints; HAQ, Health Assessment Questionnaire; CMV, cytomegalovirus; EBV, Epstein-Barr virus; DMARD, disease-modifying antirheumatic drug.